医学
斑块性银屑病
皮肤病科
银屑病
梅德林
政治学
法学
作者
Joshua Burshtein,Milaan Shah,Danny Zakria,April W. Armstrong,Alexandra Golant,Alice B. Gottlieb,Jeffrey M Weinberg,Leon Kircik,George Han,Richard Langley,Andrea L. Neimann,Mark Lebwohl
摘要
Plaque psoriasis is a chronic, relapsing systemic illness that has a significant effect on quality of life. Bimekizumab is the first monoclonal antibody to target both interleukin (IL)-17A and IL-17F, and recently received Food and Drug Administration (FDA) approval for moderate to severe plaque psoriasis. Guidance is necessary regarding the safety of bimekizumab.
科研通智能强力驱动
Strongly Powered by AbleSci AI
cdercder
ceeray23
剑指东方是为谁
痴情的博超
YifanWang
tuanheqi
昏睡的蟠桃
斯寜
back you up
zhongu
SYLH
wuludie
贰鸟
MchemG
有人
HEIKU
小乔
nebula
nino
pluto
皖公网安备34019202002308
